Valuation : Guerbet

Market Cap 95.37M 111M 89.73M 81.97M 153M 10.46B 154M 1.06B 411M 5.37B 416M 407M 17.3B P/E 2026 *
-4.24x
P/E 2027 * 8.23x
Enterprise Value 471M 547M 443M 405M 757M 51.68B 759M 5.24B 2.03B 26.51B 2.06B 2.01B 85.41B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.58x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.09%
1 day-0.13%
1 week-2.08%
Current month-2.08%
1 month-9.04%
3 months-26.56%
6 months-38.72%
Current year-47.20%
1 week 7.45
Extreme 7.45
7.72
1 month 7.45
Extreme 7.45
8.41
Current year 7.43
Extreme 7.43
15.12
1 year 7.43
Extreme 7.43
20
3 years 7.43
Extreme 7.43
40.25
5 years 7.43
Extreme 7.43
45.65
10 years 7.43
Extreme 7.43
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 50 19/05/2017
Director/Board Member 52 22/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
6/8/26 Buy

Director

1,185 0.0094%
5/8/26 Buy

Director

5,027 0.0398%
4/8/26 Buy

Director

3,788 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-2.08%-61.00%-63.26% 111M
+3.33%+2.86%-23.88%+0.54% 13.22B
-2.36%-4.13%+10.60%+16.29% 4.23B
+3.96%+3.48%-37.52%-54.17% 1.27B
-1.36%-1.81%-36.41%-40.15% 1.14B
-3.63%-4.16%+15.92%+72.60% 1.07B
-1.80%-0.34% - - 1.03B
-0.50%-2.68%-37.21% - 1.02B
-3.35%-6.37%+25.67%+100.88% 503M
+0.34%+1.01%+67.32% - 300M
Average -0.55%-1.89%-8.50%+4.67% 2.39B
Weighted average by Cap. +1.24%+0.29%-15.51%+3.84%

Financials

2026 *2027 *
Net sales 764M 888M 719M 657M 1.23B 83.81B 1.23B 8.49B 3.3B 43B 3.33B 3.26B 139B 798M 928M 751M 686M 1.28B 87.58B 1.29B 8.87B 3.44B 44.94B 3.48B 3.41B 145B
Net income -35.8M -41.6M -33.68M -30.77M -57.56M -3.93B -57.72M -398M -154M -2.02B -156M -153M -6.49B 8.3M 9.65M 7.81M 7.13M 13.34M 911M 13.38M 92.28M 35.81M 467M 36.22M 35.43M 1.51B
Net Debt 376M 436M 353M 323M 604M 41.21B 606M 4.18B 1.62B 21.14B 1.64B 1.6B 68.12B 370M 430M 348M 318M 595M 40.63B 597M 4.12B 1.6B 20.85B 1.62B 1.58B 67.16B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
07/09/26 7.550 -0.13% 1,004
04/09/26 €7.560 -0.13% 9,455
03/09/26 €7.570 +1.20% 5,305
02/09/26 €7.480 -1.58% 27,055
01/09/26 €7.600 -1.43% 8,420
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
7.560EUR
Average target price
8.433EUR
Spread / Average Target
+11.55%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!